FDA Inspection
Ascendis Pharma LLCAscendis Pharma LLC – FDA Inspection, Mar 6, 2026
Record Details
This FDA Inspection record concerns Ascendis Pharma LLC, with an inspection on March 6, 2026, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · 6d5dd80a-ac1f-44a2-9413-1a4318eb357b
Inspection Facts
- Inspection number
- 1306552
- FDA center
- Human Drugs
- Project area
- Postmarketing Surveillance and Epidemiology: Human Drugs
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 600.80(b)Review of Adverse Experiences - SOPs
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.